Vascular comorbidities worsen prognosis of patients with heart failure hospitalised with COVID-19.

Background: Prior diagnosis of heart failure (HF) is associated with increased length of hospital stay (LOS) and mortality from COVID-19. Associations between substance use, venous thromboembolism (VTE) or peripheral arterial disease (PAD) and its effects on LOS or mortality in patients with HF hospitalised with COVID-19 remain unknown.

Objective: This study identified risk factors associated with poor in-hospital outcomes among patients with HF hospitalised with COVID-19.

Effects of Holding Beta-Blockers on the Vital Signs of Heart Failure Patients.

Background: Heart failure with reduced ejection fraction (HFrEF) is associated with recurrent hospitalizations and high mortality. Guideline-directed medical therapy (GDMT) reduces morbidity, mortality and re-admission rates. Despite the evidence, less than 50% of patients with HFrEF are prescribed appropriate medical therapy.